Solco Biomedical Co., Ltd.

KOSDAQ:A043100 Stock Report

Market Cap: ₩19.4b

Solco Biomedical Past Earnings Performance

Past criteria checks 0/6

Solco Biomedical has been growing earnings at an average annual rate of 4%, while the Medical Equipment industry saw earnings growing at 16.2% annually. Revenues have been growing at an average rate of 4.2% per year.

Key information

4.0%

Earnings growth rate

9.4%

EPS growth rate

Medical Equipment Industry Growth22.7%
Revenue growth rate4.2%
Return on equity-101.3%
Net Margin-66.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Jun 27
Is Solco Biomedical (KOSDAQ:043100) Using Debt In A Risky Way?

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Jun 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) 27% Dip In Price Shows Sentiment Is Matching Revenues

Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Feb 27
Solco Biomedical Co., Ltd.'s (KOSDAQ:043100) Share Price Boosted 40% But Its Business Prospects Need A Lift Too

Revenue & Expenses Breakdown

How Solco Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

KOSDAQ:A043100 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 2427,721-18,32616,1672,460
31 Dec 2326,878-19,96616,2922,263
30 Sep 2325,504-11,73313,9372,285
30 Jun 2324,869-11,04912,1122,356
31 Mar 2323,869-10,51911,5442,110
31 Dec 2223,396-9,52810,6171,923
30 Sep 2223,974-6,29911,8261,652
30 Jun 2223,501-5,83612,5781,535
31 Mar 2223,769-4,98311,9501,350
31 Dec 2123,951-4,07511,4981,408
30 Sep 2123,798-1757,9951,214
30 Jun 2124,316-5307,4031,155
31 Mar 2123,2091,1885,4441,188
31 Dec 2022,8541,6475,4421,018
30 Sep 2021,555-11,2569,0021,008
30 Jun 2021,158-11,5879,274833
31 Mar 2021,756-16,84114,504824
31 Dec 1921,442-18,76415,501955
30 Sep 1921,333-16,92017,5511,081
30 Jun 1922,344-17,83718,906888
31 Mar 1922,222-15,64116,360980
31 Dec 1822,541-15,35015,9611,187
30 Sep 1823,551-6,44511,5041,037
30 Jun 1823,007-7,23111,3051,037
31 Mar 1823,822-7,61310,9641,336
31 Dec 1723,211-8,52810,5101,780
30 Sep 1722,857-9,59311,3252,305
30 Jun 1722,554-9,05811,4352,305
31 Mar 1722,204-8,93511,2692,207
31 Dec 1623,722-7,98310,8752,083
30 Sep 1624,189-8,43211,9701,722
30 Jun 1624,174-8,40311,5841,722
31 Mar 1622,986-7,83811,8301,477
31 Dec 1522,432-7,00611,0401,004
30 Sep 1525,154-1,0947,3091,116
30 Jun 1525,063-2,2277,6641,116
31 Mar 1527,940-1,78212,521871
31 Dec 1430,141-2,17513,488871
30 Sep 1431,154-7,42615,703734
30 Jun 1433,051-5,58816,262734
31 Mar 1434,506-5,47411,354820
31 Dec 1335,499-5,01611,721879
30 Sep 1337,017-5,12413,036711
30 Jun 1339,503-4,29612,242930

Quality Earnings: A043100 is currently unprofitable.

Growing Profit Margin: A043100 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: A043100 is unprofitable, but has reduced losses over the past 5 years at a rate of 4% per year.

Accelerating Growth: Unable to compare A043100's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A043100 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (4.1%).


Return on Equity

High ROE: A043100 has a negative Return on Equity (-101.3%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.